Fundraising FoxKickfund — 2026 Investments
4 investments dated 2026 · listed companies and verified rows first · show all
Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments.
BiotechDeep TechMedical DevicesZürich, CH
Amir Taheri(Co-founder and Chief Scientific Officer)inJacob Corn(Co-founder and Scientific Advisor)inJan Nelis(Co-founder and Chief Executive Officer)in
Co-investorsOCCIDENTanother.vcBackbone VenturesVenture Kick
Clee Medical develops a real-time intraoperative brain imaging platform called Neuro to support neurosurgical procedures.
Deep TechHealthtechMedical Devices
Co-investorsCreative Destruction Lab (CDL)High Tech GruenderfondsHTGFVenture Kick
Cosaic develops ingredient solutions to create resilient food systems that align with consumer preferences.
AgTechBiotechFoodTechNew Materials
Dimitri Zogg(Co-Founder & CTO)inTomas Turner(Co-Founder & CEO)in
Co-investorsNavus VenturesIlluminate Financial
Seprify produces functional cellulose-based ingredients from renewable plant resources for industrial applications, offering biodegradable cellulose particles that serve as lower-carbon alternatives to conventional materials such as titanium dioxide.
Circular EconomyCleantechNew MaterialsMarly, CH
Oliver Polcher(Founder)in
Co-investorsBig Idea VenturesUna Terra
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.